Evaluating drug prevention in the European Union: papers arising from the First European Conference on the Evaluation of Drug Prevention held in Lisbon, Portugal, 12 - 14 march 1997

Preventing drug use is a universal challenge and identifying approaches that work, and why they work, is a specific objective for drug professionals and evaluators. This monograph focuses on the ideology of prevention in Europe. In particular, it presents arguments for making evaluation a routine an...

Full description

Saved in:  
Bibliographic Details
Corporate Authors: Europäische Kommission, Beobachtungsstelle für Drogen und Drogensucht (Issuing body) ; European Conference on the Evaluation of Drug Prevention 1 1997, Lissabon (Creator)
Contributors: Baker, Oswin (Editor) ; Europäische Kommission Beobachtungsstelle für Drogen und Drogensucht ; European Conference on the Evaluation of Drug Prevention
Format: Electronic Book
Language:English
Published: Luxemburg Office for Official Publications of the European Communities 1998
In: EMCDDA scientific monograph series (2)
Online Access: Volltext (kostenfrei)
Volltext (kostenfrei)
Volltext (kostenfrei)
Check availability: HBZ Gateway
Keywords:
Drogenmissbrauch
Europäische Union
Konferenzschrift
Prävention
Related Items:Erscheint auch als: 1630815349
Description
Summary:Preventing drug use is a universal challenge and identifying approaches that work, and why they work, is a specific objective for drug professionals and evaluators. This monograph focuses on the ideology of prevention in Europe. In particular, it presents arguments for making evaluation a routine and scientifically sound procedure that draws on good practice and proven methodology. The volume includes a broad overview of the history and status of prevention activities and their evaluation in Europe and the US, as well as an introduction to the theoretical foundations of evaluation. Also reviewed are the most commonly encountered evaluation methods, instruments, problems and obstacles and the diversity and complexity of evaluation models. The monograph explores how drug professionals can interest politicians in evaluation and how evaluation can stimulate the allocation of funds.
Physical Description:1 Online-Ressource (139 Seiten)
DOI:10.15496/publikation-23194